Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1986 Sep;49(9):1088–1090. doi: 10.1136/jnnp.49.9.1088

Beneficial effect of physostigmine on clinical amnesic behaviour and neuropsychological test results in a patient with a post-encephalitic amnesic syndrome.

C E Catsman-Berrevoets, F Van Harskamp, A Appelhof
PMCID: PMC1029023  PMID: 3760902

Full text

PDF
1088

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buschke H., Fuld P. A. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974 Nov;24(11):1019–1025. doi: 10.1212/wnl.24.11.1019. [DOI] [PubMed] [Google Scholar]
  2. Cermak L. S., O'Connor M. The anterograde and retrograde retrieval ability of a patient with amnesia due to encephalitis. Neuropsychologia. 1983;21(3):213–234. doi: 10.1016/0028-3932(83)90039-8. [DOI] [PubMed] [Google Scholar]
  3. Greenwood R., Bhalla A., Gordon A., Roberts J. Behaviour disturbances during recovery from herpes simplex encephalitis. J Neurol Neurosurg Psychiatry. 1983 Sep;46(9):809–817. doi: 10.1136/jnnp.46.9.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hartje W., Rixecker H. Der Recurring-Figures-Test von Kimura. Normierung an einer deutschen Stichprobe. Nervenarzt. 1978 Jun;49(6):354–356. [PubMed] [Google Scholar]
  5. Mohs R. C., Davis B. M., Johns C. A., Mathé A. A., Greenwald B. S., Horvath T. B., Davis K. L. Oral physostigmine treatment of patients with Alzheimer's disease. Am J Psychiatry. 1985 Jan;142(1):28–33. doi: 10.1176/ajp.142.1.28. [DOI] [PubMed] [Google Scholar]
  6. Muramoto O., Sugishita M., Ando K. Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1984 May;47(5):485–491. doi: 10.1136/jnnp.47.5.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Peters B. H., Levin H. S. Memory enhancement after physostigmine treatment in the amnesic syndrome. Arch Neurol. 1977 Apr;34(4):215–219. doi: 10.1001/archneur.1977.00500160029004. [DOI] [PubMed] [Google Scholar]
  8. ROSE F. C., SYMONDS C. P. Persistent memory defect following encephalitis. Brain. 1960;83:195–212. doi: 10.1093/brain/83.2.195. [DOI] [PubMed] [Google Scholar]
  9. Thal L. J., Fuld P. A., Masur D. M., Sharpless N. S. Oral physostigmine and lecithin improve memory in Alzheimer disease. Ann Neurol. 1983 May;13(5):491–496. doi: 10.1002/ana.410130504. [DOI] [PubMed] [Google Scholar]
  10. Walton R. G. Lecithin and physostigmine for posttraumatic memory and cognitive deficits. Psychosomatics. 1982 Apr;23(4):435–436. doi: 10.1016/S0033-3182(82)73406-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES